HomeCLN • WSE
add
Celon Pharma SA
Nakaraang pagsara
zł 20.00
Sakop ng araw
zł 19.90 - zł 20.15
Sakop ng taon
zł 19.60 - zł 28.65
Market cap
1.08B PLN
Average na Volume
12.40K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Mga balita tungkol sa merkado
Times Colonist
6 oras ang nakalipas
Tech stocks weigh on Canadian, U.S. markets while pot stocks surge
0.42%
Mga Financial
Income Statement
Kita
Net na kita
| (PLN) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 71.13M | 39.34% |
Gastos sa pagpapatakbo | 46.24M | 297.41% |
Net na kita | 3.66M | -93.59% |
Net profit margin | 5.15 | -95.40% |
Kita sa bawat share | — | — |
EBITDA | 16.34M | -76.60% |
Aktuwal na % ng binabayarang buwis | 232.29% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (PLN) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 21.03M | -79.64% |
Kabuuang asset | 471.34M | -23.87% |
Kabuuang sagutin | 82.14M | -20.18% |
Kabuuang equity | 389.19M | — |
Natitirang share | 53.86M | — |
Presyo para makapag-book | 2.77 | — |
Return on assets | 4.23% | — |
Return on capital | 4.99% | — |
Cash Flow
Net change in cash
| (PLN) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 3.66M | -93.59% |
Cash mula sa mga operasyon | -4.88M | 66.89% |
Cash mula sa pag-invest | 10.02M | 347.12% |
Cash mula sa financing | -6.93M | -389.68% |
Net change in cash | -1.78M | 91.17% |
Malayang cash flow | 4.87M | -85.31% |
Tungkol
Itinatag
2002
Website
Mga Empleyado
566
